# PET Neuroimaging of [11C]Mirtazapine

> **NCT00288782** · PHASE4 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 24 (—)

## Conditions studied

- Mental Disorders
- Mood Disorders
- Affective Disorders
- Depressive Disorders

## Interventions

- **DRUG:** Mirtazapine

## Key facts

- **NCT ID:** NCT00288782
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 24 (—)
- **Last updated:** 2007-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288782, "PET Neuroimaging of [11C]Mirtazapine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00288782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
